Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,700 | 16,040 | 12,490 | 7,740 | 4,880 |
| Marketable Securities | 24,550 | 30,030 | 69,040 | 27,170 | 41,310 |
| Receivables | 43,170 | 34,500 | 74,840 | 15,090 | 3,250 |
| Inventories | 17,760 | 11,570 | 16,330 | 5,360 | 1,670 |
| Other current assets | 11,060 | 4,260 | 3,730 | 1,700 | 1,150 |
| TOTAL | $120,240 | $96,400 | $176,430 | $57,060 | $52,260 |
| Non-Current Assets | |||||
| PPE Net | 16,530 | 14,030 | 21,680 | 9,950 | 10,040 |
| Other Non-Current Assets | 153,360 | 101,320 | 132,840 | 19,760 | 2,460 |
| TOTAL | $169,890 | $115,350 | $154,520 | $29,710 | $12,500 |
| Total Assets | $290,130 | $211,770 | $330,960 | $86,790 | $64,770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,080 | 2,700 | 3,200 | 2,220 | 210 |
| Accounts payable and accrued liabilities | 41,740 | 37,990 | 42,550 | 15,130 | 3,940 |
| Accrued Expenses | 0 | 0 | 0 | 0 | 430 |
| Other current liabilities | 2,120 | 790 | 39,690 | 0 | 0 |
| TOTAL | $60,030 | $43,990 | $132,230 | $17,360 | $4,590 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,700 | 10,830 | 9,960 | 6,710 | 3,190 |
| Other Non-Current Liabilities | 55,780 | 59,070 | 30,710 | 11,910 | 6,470 |
| TOTAL | $130,140 | $77,460 | $88,380 | $18,620 | $9,660 |
| Total Liabilities | $190,190 | $121,470 | $220,630 | $36,000 | $14,260 |
| Shareholders' Equity | |||||
| Common Shares | 157,240 | 134,320 | 153,570 | 62,990 | 53,840 |
| Retained earnings | -65,440 | -52,270 | -44,860 | -12,320 | -3,340 |
| Other shareholders' equity | 8,130 | 2,900 | 770 | 110 | 0 |
| TOTAL | $99,930 | $90,300 | $110,330 | $50,780 | $50,500 |
| Total Liabilities And Equity | $290,120 | $211,770 | $330,960 | $86,780 | $64,760 |